MétaCan
Menu
Back to cohort
Record W4416827536 · doi:10.1080/15384047.2025.2589666

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma

2025· article· en· W4416827536 on OpenAlexafffund
Piotr Manasterski, Henry Beetham, John C. Dawson, Richard Elliott, Jayne Culley, Rashi Krishna, Morwenna Muir, John P. Thomson, Ailsa J. Oswald, Ailith Ewing, William Kerrison, Paul H. Huang, Ioanna Nixon, Neil O. Carragher, Valerie G. Brunton

Bibliographic record

VenueCancer Biology & Therapy · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicHistone Deacetylase Inhibitors Research
Canadian institutionsInstitute of Cancer Research
FundersMedical Research CouncilInstitute of GeneticsChief Scientist OfficeDepartment of Health and Social CareCancer Research UKWellcome TrustNational Institute for Health and Care ResearchSarcoma UK
KeywordsHistone deacetylaseSoft tissue sarcomaDoxorubicinHistoneSarcomaHistone deacetylase inhibitorHistone deacetylase 2

Abstract

fetched live from OpenAlex

Background Undifferentiated pleomorphic sarcoma (UPS) is a rare and aggressive soft tissue sarcoma with limited treatment options and a poor prognosis. As a complex karyotype tumor, UPS lacks recurrent targetable mutations, and response rates to standard first-line doxorubicin therapy are low. Phenotypic drug screening offers an alternative approach to identify new therapeutic targets without requiring prior knowledge of molecular mechanisms.Methods A library of FDA-approved compounds and a custom histone deacetylase (HDAC) inhibitor library were screened using well-annotated patient-derived cell lines. Hit compounds were further characterized using apoptosis assays and in vivo xenograft studies. Biomarkers of activity were evaluated using gene expression and western blot analyses. Synergy with doxorubicin was evaluated in combination assays.Results HDAC inhibitors emerged as a promising therapeutic class, demonstrating low IC50 values across cell lines (14.8−26.89 nM), with quisinostat taken forward for further evaluation. Gene expression changes in EPAS1, FOXO1, AMOT, and FOSL1 were observed as potential biomarkers of activity. Combination assays revealed synergy between quisinostat and doxorubicin (average ZIP score: 1.02−15.65; ZIPmax: 3.98−33.71), increasing apoptotic cell death in vitro. In vivo, quisinostat alone and in combination with doxorubicin significantly reduced the tumor volume (vehicle 160.0 ± 63.2 mm3, doxorubicin 78.0 ± 35.2 mm3, quisinostat 84.3 ± 13.1 mm3, and combination 49.2 ± 10.2 mm3). Quisinostat also showed potent activity in leiomyosarcoma (LMS) cell lines (5.82−31.32 nM), which represent an additional complex karyotype soft tissue sarcoma.Conclusions Quisinostat demonstrated strong preclinical activity and synergy with standard-of-care doxorubicin in models of UPS and LMS.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.059
Threshold uncertainty score0.706

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.345
Teacher spread0.324 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueCancer Biology & TherapySame topicHistone Deacetylase Inhibitors ResearchFrench-language works237,207